{
    "clinical_study": {
        "@rank": "68733", 
        "arm_group": {
            "arm_group_label": "Cohort"
        }, 
        "biospec_descr": {
            "textblock": "Formalin-fixed paraffin-embedded (FFPE) tumor samples"
        }, 
        "biospec_retention": "None Retained", 
        "brief_summary": {
            "textblock": "This is a screening study to detect BRAF V600 mutation-positive patients for enr ollment\n      into clinical research studies of Zelboraf (vemurafenib). Tumor samples will be collected\n      and analyzed from eligible patients with solid tumors (other t han metastatic melanoma or\n      papillary thyroid cancer) or multiple myeloma. All in stitutions with identified patients as\n      defined by this screening protocol will h ave potential access to the separate vemurafenib\n      protocol MO28072."
        }, 
        "brief_title": "A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": "Multiple Myeloma, Neoplasms", 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Multiple Myeloma", 
                "Neoplasms, Plasma Cell"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically confirmed solid tumors (excluding melanoma and papillary thyroid\n             cancer) or multiple myeloma refractory to standard therapy or for which standard or\n             curative therapy does not exist or is not considered appropriate by the investigator\n\n          -  Patients with multiple myeloma must have received at least one line of prior systemic\n             therapy for the treatment of multiple myeloma\n\n        Exclusion Criteria:\n\n          -  Eastern Cooperative Oncology Group (ECOG) performance status > 2\n\n          -  Uncontrolled concurrent malignancy\n\n          -  Active or untreated CNS metastases\n\n          -  History of known carcinomatous meningitis\n\n          -  Prior treatment with a BRAF or MEK inhibitor (prior sorafenib is allowed)\n\n          -  Uncontrolled, severe medical illness or condition as defined in protocol MO28072"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with solid tumors (other than metastatic melanoma or papillary thyroid cancer) or\n        multiple myeloma"
            }
        }, 
        "enrollment": {
            "#text": "658", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01804140", 
            "org_study_id": "ML28560"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 2, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Sedona", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "86336"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85704"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Burbank", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91505"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rancho Cucamonga", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91730"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80218"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ocala", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34471"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Woodbury", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55125"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbia", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "65201"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89169"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37232"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amarillo", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "79106"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78705"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75237"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75231"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75246"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denton", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "76210"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "McAllen", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78503"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tyler", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75702"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Spokane", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "99204"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yakima", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98902"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Screening Protocol to Detect BRAF V600 Mutation-Positive Patients for Enrollment Into Clinical Research Studies of Vemurafenib", 
        "overall_official": {
            "affiliation": "Genentech", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Incidence of BRAF V600 mutation positivity in tumor samples", 
                "safety_issue": "No", 
                "time_frame": "approximately 12 months"
            }, 
            {
                "measure": "Description of BRAF V600 mutation patterns in tumor samples", 
                "safety_issue": "Yes", 
                "time_frame": "approximately 12 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01804140"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Genentech", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Genentech", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2014"
    }
}